AI-generated content for informational purposes only. Not financial advice. Always do your own research.

Über uns

Telehealth-Plattform, die personalisierte Gesundheits- und Wellness-Lösungen für Männer und Frauen bietet, einschließlich Dermatologie, psychische Gesundheit, sexuelle Gesundheit und Gewichtsmanagement-Behandlungen.

Small Cap Growth-Aktien

Hims & Hers ist eine schnell wachsende Telemedizin-Plattform, die personalisierte Wellness-Lösungen für Haarausfall, Hautpflege, sexuelle Gesundheit und psychische Gesundheit durch ein Direct-to-Consumer-Modell anbietet.

Key Financials HIMS

Preis $16.30
Veränderung (1T) +3.16%
Veränderung (30D) -49.80%
Veränderung (60D) -54.19%
Veränderung (90D) -70.23%
Veränderung (180D) -69.44%
Veränderung (1Y) -64.83%
Veränderung (5Y) -30.64%
KGV 20.63
EPS (TTM) $0.79
52-Wochen-Spanne $15.63 — $72.98
50-Tage-Durchschnitt $31.23
Volumen 26.12M

Data updated Feb 15 · Source: Twelve Data

2.8
1 reviews
Valuation
3.2
Fundamentals
3
Management Quality
2.8
Performance
2.2
Risk Profile
2
Claude Opus 4.6
AI Review
2.8/5

Hims & Hers Health operates a telehealth platform offering personalized health and wellness products, primarily in men's and women's health categories including hair loss, sexual health, and skincare. The company has demonstrated strong revenue growth and achieved profitability, with a TTM EPS of $0.79 and a now-reasonable P/E of 20.63 following a dramatic selloff.

The stock has experienced a devastating decline of over 70% from its 52-week high of $72.98, largely driven by regulatory concerns around compounded GLP-1 medications (semaglutide) and FDA actions that threaten a significant revenue stream. Trading well below its 50-day moving average of $31.23, the technical picture is deeply bearish.

Bull case: The core telehealth platform remains viable with a loyal subscriber base, the valuation is now compelling for a growth company, and management has diversified product offerings. Bear case: GLP-1 regulatory headwinds could materially impact revenue projections, competitive pressures from traditional healthcare providers are intensifying, and the stock may need time to find a floor. The elevated volume suggests ongoing institutional repositioning. This is a high-risk, potentially high-reward situation best suited for investors with strong conviction and patience.

Valuation
3.2
Fundamentals
3
Management Quality
2.8
Performance
2.2
Risk Profile
2
Feb 15, 2026
Hims & Hers Health Screenshot

Added: Feb 15, 2026

forhims.com

Latest from Otrai

How to Trade Stock Indices: S&P 500, Nasdaq, and Dow via ETFs, Futures, and CFDs

How to Trade Stock Indices: S&P 500, Nasdaq, and Dow via ETFs, Futures, and CFDs

A stock index is a single number that summarizes the price action of a basket of companies. The S&P 500 tracks roughly 500 large US firms, the Nasdaq-100 tracks the 100 largest non-financial names on the Nasdaq exchange, and the Dow Jones Industrial Average follows 30 blue-chip stocks.

The Options Greeks Explained: Delta, Gamma, Theta, and Vega

The Options Greeks Explained: Delta, Gamma, Theta, and Vega

The Greeks explain why an option costs what it costs and how that price changes when the stock moves, time passes, and volatility shifts. Delta, Gamma, Theta, and Vega, made accessible.

Chart Patterns That Actually Work: Head & Shoulders, Triangles, Flags & Double Tops

Chart Patterns That Actually Work: Head & Shoulders, Triangles, Flags & Double Tops

Chart patterns are the most recognizable part of technical analysis and the most misunderstood. Most fail or break out the wrong way before reversing. This guide covers head and shoulders, double tops and bottoms, triangles, and flags — with realistic reliability, target measurement, and false-breakout confirmation.

So backtesten Sie eine Handelsstrategie: Methoden, Fallstricke und was die Ergebnisse tatsächlich bedeuten

So backtesten Sie eine Handelsstrategie: Methoden, Fallstricke und was die Ergebnisse tatsächlich bedeuten

Jeder Trader hat eine Strategie, die in seinem Kopf großartig aussieht. Backtesting ist die Art herauszufinden, ob sie tatsächlich funktioniert. Hier erfahren Sie, wie Sie Strategien richtig testen, welche Kennzahlen wichtig sind und warum die meisten Backtest-Ergebnisse zu gut sind, um wahr zu sein.